Fields of Research (FoR)
Medical Genetics, Cancer Genetics, Epigenetics (incl. Genome Methylation and Epigenomics), PathologySEO tags
Biography
Associate Professor Luke Hesson is a Clinical Genetics Scientist and cancer researcher. He holds a doctorate in Clinical Genetics from The University of Birmingham UK and is a Fellow of the Faculty of Science of the Royal College of Pathologists of Australasia (RCPA). He is affiliated with Douglass Hanly Moir Pathology where he provides scientific supervision of the Molecular Genetics Department, UNSW Sydney where he lectures in genetics,...view more
Associate Professor Luke Hesson is a Clinical Genetics Scientist and cancer researcher. He holds a doctorate in Clinical Genetics from The University of Birmingham UK and is a Fellow of the Faculty of Science of the Royal College of Pathologists of Australasia (RCPA). He is affiliated with Douglass Hanly Moir Pathology where he provides scientific supervision of the Molecular Genetics Department, UNSW Sydney where he lectures in genetics, epigenetics, cancer, pathology and personalised medicine, and is a Visiting Scientist at the Garvan Institute of Medical Research. He is a Technical Assessor for the National Association of Testing Authorities (NATA), a member of the RCPA Quality Assurance Program Advisory Committee, and former Director of the Australian Society for Medical Research.
He has 20 years’ experience investigating the genetic and epigenetic causes of cancer with >80 peer-reviewed publications (>4500 citations, h-index 34) and has contributed to knowledge of the genes and types of molecular alterations that contribute to a range of diseases. This includes the development of clinically accredited genetic tests for use by pathology laboratories.
My Grants
Awarded $4M AUD in funding as Chief Investigator.
Co-Chief Investigator, Harnessing the power from within: Neoantigen immunopeptidomics for the development of immunotherapies for the treatment of diffuse intrinsic pontine glioma (DIPG) (2020-2023), $326,389
Project Lead, MTPConnect, BioMedTech Horizons Project, A clinically-accredited and commercial-ready genome profiling platform to enable precision cancer medicine (2018-2020), $1,817,678
Consortium Lead, MTPConnect, Enabling Precision Cancer Clinical Trials (2018-2020), $828,540
Co-Chief Investigator, Anthony Rothe Memorial Trust (2016-2017), $200,000
Co-Chief Investigator, Big Data Big Impact Grant, Cancer Institute New South Wales (2013-2014), $210,000
Co-applicant, UNSW Faculty Research Grant (2012), $20,000
Chief Investigator, Cancer Institute New South Wales Fellowship (2010-2012), $599,883
My Qualifications
Fellow of the Faculty of Science of the Royal College of Pathologists of Australasia (FFSc RCPA (Research)), 2017
PhD (Clinical Genetics), University of Birmingham, 2005
BMedSc (Hons), University of Birmingham, 2001
My Awards
Breast Cancer Campaign UK the Team of the Year 2004 Prize, awarded in a ceremony at The House of Lords, Westminster, London.